GB201804816D0 - Cancer treatment - Google Patents

Cancer treatment

Info

Publication number
GB201804816D0
GB201804816D0 GBGB1804816.5A GB201804816A GB201804816D0 GB 201804816 D0 GB201804816 D0 GB 201804816D0 GB 201804816 A GB201804816 A GB 201804816A GB 201804816 D0 GB201804816 D0 GB 201804816D0
Authority
GB
United Kingdom
Prior art keywords
cancer treatment
cancer
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1804816.5A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Anglia Ruskin Univ Higher Education Corp
Original Assignee
Anglia Ruskin Univ Higher Education Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anglia Ruskin Univ Higher Education Corp filed Critical Anglia Ruskin Univ Higher Education Corp
Priority to GBGB1804816.5A priority Critical patent/GB201804816D0/en
Publication of GB201804816D0 publication Critical patent/GB201804816D0/en
Priority to PCT/EP2019/056677 priority patent/WO2019185387A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/223—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of alpha-aminoacids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB1804816.5A 2018-03-26 2018-03-26 Cancer treatment Ceased GB201804816D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1804816.5A GB201804816D0 (en) 2018-03-26 2018-03-26 Cancer treatment
PCT/EP2019/056677 WO2019185387A1 (en) 2018-03-26 2019-03-18 Cancer treatment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1804816.5A GB201804816D0 (en) 2018-03-26 2018-03-26 Cancer treatment

Publications (1)

Publication Number Publication Date
GB201804816D0 true GB201804816D0 (en) 2018-05-09

Family

ID=62067981

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1804816.5A Ceased GB201804816D0 (en) 2018-03-26 2018-03-26 Cancer treatment

Country Status (2)

Country Link
GB (1) GB201804816D0 (en)
WO (1) WO2019185387A1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1802324B1 (en) * 2004-09-22 2010-06-02 VIB vzw Inhibitors of taste receptors for use in the treatment of obesity and diabetes
US20080305500A1 (en) * 2007-06-08 2008-12-11 Senomyx, Inc. Novel cell-based assays for identifying enhancers or inhibitors of t1r taste receptors (t1r2/t1r3 sweet) and umami (t1r1/t1r3 umami) taste receptors
EP2197433A4 (en) * 2007-08-20 2010-09-08 Sinai School Medicine Regulating glp-1 and sglt-1 in gastrointestinal cells
US11938200B2 (en) * 2016-02-05 2024-03-26 The Trustees Of The University Of Pennsylvania Non-nutritive sweeteners and polyols as imaging agents

Also Published As

Publication number Publication date
WO2019185387A1 (en) 2019-10-03

Similar Documents

Publication Publication Date Title
IL271946A (en) Combination cancer therapy
IL263802A (en) Cancer treatment combinations
ZA202005847B (en) Cancer therapy
PT3576740T (en) Cancer treatment
GB201903546D0 (en) Cancer treatment
GB201813876D0 (en) Treatment
GB201820660D0 (en) Cancer treatments
SG11202011117VA (en) Treatment of cancer
GB201706451D0 (en) Cancer treatment
IL287652A (en) Cancer treatment
IL282093A (en) Combination therapy for cancer
SG11202010528XA (en) Combinations for treating cancer
GB201800546D0 (en) Treatment
IL268463A (en) Cancer treatment
IL285466A (en) Cancer treatment
HK1251794A1 (en) Cancer treatment
GB201800733D0 (en) Cancer
IL274626A (en) Cancer treatment
GB201814487D0 (en) Cancer
EP3576791A4 (en) Calreticulin-mediated cancer treatment
IL288035A (en) Cancer treatment
GB201707864D0 (en) Platinum-reistant cancer treatment
GB201704909D0 (en) Cancer therapy
GB201819920D0 (en) Cancer treatment
GB201711855D0 (en) Cancer therapy

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)